PlainRecalls
FDA Drug Low Class III Ongoing

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01

Reported: October 1, 2025 Initiated: August 28, 2025 #D-0671-2025

Product Description

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01

Reason for Recall

Failed Impurities/Degradation Specifications:

Details

Units Affected
9,917 bottles
Distribution
Distributed Nationwide in the USA
Location
Chantilly, VA

Frequently Asked Questions

What product was recalled?
Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01. Recalled by Granules Pharmaceuticals Inc.. Units affected: 9,917 bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications:
Which agency issued this recall?
This recall was issued by the FDA Drug on October 1, 2025. Severity: Low. Recall number: D-0671-2025.